315228-46-7 Usage
Uses
Used in Pharmaceutical Industry:
6-Methylquinolin-3-ol is used as an intermediate in the production of pharmaceuticals for its potential therapeutic applications in the treatment of diseases associated with abnormal PRK2 function, such as cancer and neurodegenerative disorders.
Used in Agrochemical Industry:
6-Methylquinolin-3-ol is used as an intermediate in the production of agrochemicals, contributing to the development of new and effective products for agricultural applications.
Used in Anticancer Applications:
6-MQ is used as a potential therapeutic agent for its ability to inhibit the protein kinase C-related kinase (PRK2), which is involved in various signaling pathways within the cell, and may have potential applications in the treatment of cancer.
Used in Neurodegenerative Disorder Treatment:
6-MQ is used as a potential therapeutic agent for its potential applications in the treatment of neurodegenerative disorders due to its ability to target abnormal PRK2 function.
Used in Antioxidant and Anti-Inflammatory Applications:
6-MQ is used for its antioxidant and anti-inflammatory properties, which may further expand its potential uses in various fields of medicine and industry, such as in the development of new drugs and treatments for inflammatory and oxidative stress-related conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 315228-46-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,5,2,2 and 8 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 315228-46:
(8*3)+(7*1)+(6*5)+(5*2)+(4*2)+(3*8)+(2*4)+(1*6)=117
117 % 10 = 7
So 315228-46-7 is a valid CAS Registry Number.
315228-46-7Relevant academic research and scientific papers
Therapeutic modulation of PPARgamma activity
-
Page/Page column 79, (2010/02/14)
Modulators of PPARγ activity are used in methods of treating and/or preventing conditions such as osteoporosis, Alzheimer's disease, psoriasis and acne, and cancer.
Compounds for the modulation of PPARgamma activity
-
, (2008/06/13)
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.
